Chas Pulido

Chas Pulido

Founder at
Alix Ventures
Health Technology
Technology Services
Commercial Services

Profile

Chas Pulido is the founder of Alix Ventures, which was founded in 2019.
He is currently an investor at Clora LLC, Mythic Therapeutics, Inc., Arc Care, Inc., Xilis, Inc., Elegen Corp., 64-X, Inc., Endpoint Health, Inc., Basil Systems, Inc., Teiko Bio, Inc., and Zafrens, Inc. He is also an advisor and first investor at Getlabs, Inc. and an advisor at Membio, Inc. Mr. Pulido received his undergraduate degree from the University of Notre Dame.

Chas Pulido active positions

CompaniesPositionStart
Founder 2018-12-31
Private Equity Investor 2019-12-31
Private Equity Investor 2021-12-31
Private Equity Investor 2020-12-31
Private Equity Investor 2020-12-31
Private Equity Investor 2020-12-31
Private Equity Investor 2019-12-31
Consultant / Advisor 2018-12-31
Private Equity Investor 2020-12-31
░░░░░ ░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░

Training of Chas Pulido

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

1

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies14

Consumer Services

Technology Services

Health Technology

Technology Services

Health Technology

Finance

Health Technology

Commercial Services

Commercial Services

Health Technology

Technology Services

Technology Services

Health Technology

Health Technology